343 related articles for article (PubMed ID: 36579669)
1. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review).
Naser R; Fakhoury I; El-Fouani A; Abi-Habib R; El-Sibai M
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579669
[TBL] [Abstract][Full Text] [Related]
2. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
3. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
4. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
6. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra.
Cheng B; Yu Q; Wang W
J Biomed Sci; 2023 Jan; 30(1):1. PubMed ID: 36600243
[TBL] [Abstract][Full Text] [Related]
7. Targeting the microenvironment in solid tumors.
Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation in the tumor microenvironment.
Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
Tajaldini M; Saeedi M; Amiriani T; Amiriani AH; Sedighi S; Mohammad Zadeh F; Dehghan M; Jahanshahi M; Zanjan Ghandian M; Khalili P; Poorkhani AH; Alizadeh AM; Khori V
Eur J Pharmacol; 2022 Aug; 928():175087. PubMed ID: 35679891
[TBL] [Abstract][Full Text] [Related]
10. Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity.
Mansouri S; Heylmann D; Stiewe T; Kracht M; Savai R
Elife; 2022 Sep; 11():. PubMed ID: 36074553
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
12. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
Li D; Xu W; Chang Y; Xiao Y; He Y; Ren S
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(6):956-973. PubMed ID: 37294106
[TBL] [Abstract][Full Text] [Related]
13. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment.
Zhu W; Liu X; Yang L; He Q; Huang D; Tan X
Eur J Pharmacol; 2023 Dec; 961():176124. PubMed ID: 37925133
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
16. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
17. The tumor microenvironment: shaping cancer progression and treatment response.
Desai SA; Patel VP; Bhosle KP; Nagare SD; Thombare KC
J Chemother; 2024 Jan; ():1-30. PubMed ID: 38179655
[TBL] [Abstract][Full Text] [Related]
18. Targeting the tumor stroma for cancer therapy.
Xu M; Zhang T; Xia R; Wei Y; Wei X
Mol Cancer; 2022 Nov; 21(1):208. PubMed ID: 36324128
[TBL] [Abstract][Full Text] [Related]
19. The updated landscape of tumor microenvironment and drug repurposing.
Jin MZ; Jin WL
Signal Transduct Target Ther; 2020 Aug; 5(1):166. PubMed ID: 32843638
[TBL] [Abstract][Full Text] [Related]
20. Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment.
Ivey JW; Bonakdar M; Kanitkar A; Davalos RV; Verbridge SS
Cancer Lett; 2016 Sep; 380(1):330-9. PubMed ID: 26724680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
